Similarly, CD204, a specific marker of tumor-associated macrophages (TAMs), was demonstrated to independently predict poor outcomes in glioma patients and its expression was closely associated with many immune checkpoint proteins including TIM-3 using the CGGA and TCGA dataset [92]. This evidence concerns the gene HAVCR2 and glioma.